ArticleBotanical studies2015
Investigation of metabolites accumulation in medical plant Gentiana rigescens during different growing stage using LC-MS/MS and FT-IR.
Article in Botanical studies, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- Defining Phytochemical Metabolomes of Somatic HybridsMolecules (Basel, Switzerland) · 2025Article
- Investigation of a Medical Plant for Hepatic Diseases with Secoiridoids Using HPLC and FT-IR Spectroscopy for a Case ofMolecules (Basel, Switzerland) · 2020Article
- Inhibition of HIV-1 Protease byEvidence-based complementary and alternative medicine : eCAM · 2020Article
- Analytical Methods of Phytochemicals from the Genus Gentiana.Molecules (Basel, Switzerland) · 2017Review
- Quantitative and Qualitative Characterization ofJournal of analytical methods in chemistry · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGentiana rigescens, an important medicinal plant in China, has been widely cultivated in Yunnan province, China. Previous studies were focused on analysis and determination of the metabolites isolated from this species, the accumulation of these metabolites during growth period are not yet clear. In this study, samples for the experiments were obtained by tissue culture. FT-IR and LC-MS/MS method were performed to distinguish the variation on the major metabolites in G. rigescens during growing stage when combined with chemometrics.
resultsMethodology validations were all within the required limits. The metabolites were visually different in tissue culture samples and mature plants. The diversity of metabolites increased proportionally with plant growth. The quantitative analysis showed the content of gentiopicroside was significantly vary during different growing stage. The highest content of gentiopicroside (122.93 ± 7.01 mg/g) was detected in leaf of regenerated plantlet, whereas its content in root significantly increased along with underground parts growth. Moreover, flavonoids mainly distributed in aerial parts showed potential competitive relationship during plant growth.
conclusionThe distribution and accumulation of metabolites are associated with different parts and plant growth, which provide potential evidences for the rational application and exploitation of G. rigescens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.